Atlas Trials

NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

Clinical trial NCT06653829 · COMPLETED

Trial details

NCT number
NCT06653829
Sponsor
North Shore Therapeutics, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Negative Symptoms in SchizophreniaSchizophreniaSchizoaffective Disorder
Start date
2023-11-06
Primary completion
2024-08-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.